Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-carbohydrate ketogenic diet in Mc Ardle's disease: a single-blinded randomized controlled trial.

Journal of neurology·2025
Same author

Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada.

Clinical toxicology (Philadelphia, Pa.)·2022
Same author

Multimodal MRI Longitudinal Assessment of White and Gray Matter in Different SPG Types of Hereditary Spastic Paraparesis.

Frontiers in neuroscience·2020
Same author

Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.

Harm reduction journal·2020
Same author

Iridociliary melanoma - Clinical case.

Journal of medicine and life·2016
Same author

Carbohydrate intake, obesity, metabolic syndrome and cancer risk? A two-part systematic review and meta-analysis protocol to estimate attributability.

BMJ open·2016
Same journal

[Macular serpiginous choroiditis complicated by macular hole].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Therapeutic approach in persistent diabetic macular edema].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Preliminary results of treatment with aflibercept].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

MANAGEMENT OF DIABETIC RETINOPATHY, PREVALENCE AND CLINICAL CLASSIFICATION.

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Changes in intraocular pressure depending on posture].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Treatment for penetrating wound caused by metallic intraocular foreign body].

Oftalmologia (Bucharest, Romania : 1990)·2015
See all related articles

Related Experiment Video

Updated: Jun 9, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

[Neuroprotection in glaucoma].

C Stefan, Diana Melinte-Dumitrica, Daniela Selaru

    Oftalmologia (Bucharest, Romania : 1990)
    |September 11, 2010
    PubMed
    Summary
    This summary is machine-generated.

    This review covers neuroprotection and glaucoma pathophysiology, highlighting advancements in glaucoma and neuroprotective treatments to improve patient outcomes.

    More Related Videos

    An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
    09:46

    An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

    Published on: July 15, 2025

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
    09:26

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

    Published on: March 23, 2016

    Related Experiment Videos

    Last Updated: Jun 9, 2026

    Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
    08:30

    Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

    Published on: March 12, 2016

    An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
    09:46

    An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

    Published on: July 15, 2025

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
    09:26

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

    Published on: March 23, 2016

    Area of Science:

    • Ophthalmology
    • Neuroscience
    • Pharmacology

    Context:

    • Glaucoma is a leading cause of irreversible blindness.
    • Neuroprotection is crucial for preventing retinal ganglion cell loss in glaucoma.
    • Current treatments primarily focus on intraocular pressure reduction.

    Purpose:

    • To provide a comprehensive review of neuroprotection in glaucoma.
    • To update on the pathophysiology of glaucoma.
    • To discuss evolving neuroprotective and antiglaucoma treatment strategies.

    Summary:

    • This paper reviews fundamental neuroprotection concepts and the pathophysiology of glaucoma.
    • It details current understanding of disease mechanisms.
    • Key developments in neuroprotective and antiglaucoma therapies are emphasized.

    Impact:

    • This review offers insights into novel therapeutic targets for glaucoma.
    • It facilitates a better understanding of neuroprotective mechanisms.
    • It guides future research and clinical practice in glaucoma management.